|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kolligs FT: Diagnostics and epidemiology
of colorectal cancer. Visc Med. 32:158–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nguyen MT and Weinberg DS: Biomarkers in
colorectal cancer screening. J Natl Compr Canc Netw. 14:1033–1040.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Potter NT, Hurban P, White MN, Whitlock
KD, Lofton-Day CE, Tetzner R, Koenig T, Quigley NB and Weiss G:
Validation of a real-time PCR-based qualitative assay for the
detection of methylated SEPT9 DNA in human plasma. Clin Chem.
60:1183–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee HS, Hwang SM, Kim TS, Kim DW, Park DJ,
Kang SB, Kim HH and Park KU: Circulating methylated septin 9
nucleic acid in the plasma of patients with gastrointestinal cancer
in the stomach and colon. Transl Oncol. 6:290–296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tóth K, Sipos F, Kalmár A, Patai AV,
Wichmann B, Stoehr R, Golcher H, Schellerer V, Tulassay Z and
Molnár B: Detection of methylated SEPT9 in plasma is a reliable
screening method for both left-and right-sided colon cancers. PLoS
One. 7:e460002012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Warren JD, Xiong W, Bunker AM, Vaughn CP,
Furtado LV, Roberts WL, Fang JC, Samowitz WS and Heichman KA:
Septin 9 methylated DNA is a sensitive and specific blood test for
colorectal cancer. BMC Med. 9:1332011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahlquist DA, Taylor WR, Mahoney DW, Zou H,
Domanico M, Thibodeau SN, Boardman LA, Berger BM and Lidgard GP:
The stool DNA test is more accurate than the plasma septin-9 test
in detecting colorectal neoplasia. Clin Gastroenterol Hepatol.
10:272–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grützmann R, Molnar B, Pilarsky C,
Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F,
Roblick UJ, et al: Sensitive detection of colorectal cancer in
peripheral blood by septin 9 DNA methylation assay. PLoS One.
3:e37592008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen CH, Yan SL, Yang TH, Chen SF, Yeh YH,
Ou JJ, Lin CH, Lee YT and Chen CH: The relationship between the
methylated septin-9 DNA blood test and stool occult blood test for
diagnosing colorectal cancer in Taiwanese people. J Clin Lab Anal.
Jul 8–2016.(Epub ahead of print).
|
|
11
|
He Q, Chen HY, Bai EQ, Luo YX, Fu RJ, He
YS, Jiang J and Wang HQ: Development of a multiplex MethyLight
assay for the detection of multigene methylation in human
colorectal cancer. Cancer Genet Cytogenet. 202:1–10. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin P, Kang Q, Wang X, Yang L, Yu Y, Li N,
He YQ, Han X, Hang J, Zhang J, et al: Performance of a
second-generation methylated SEPT9 test in detecting colorectal
neoplasm. J Gastroenterol Hepatol. 30:830–833. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Johnson DA, Barclay RL, Mergener K, Weiss
G, König T, Beck J and Potter NT: Plasma Septin9 versus fecal
immunochemical testing for colorectal cancer screening: A
prospective multicenter study. PLoS One. 9:e982382014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Church TR, Wandell M, Lofton-Day C, Mongin
SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T,
Osborn N, et al: PRESEPT Clinical Study Steering Committee,
Investigators and Study Team: Prospective evaluation of methylated
SEPT9 in plasma for detection of asymptomatic colorectal cancer.
Gut. 63:317–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
deVos T, Tetzner R, Model F, Weiss G,
Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C,
Habermann JK, et al: Circulating methylated SEPT9 DNA in plasma is
a biomarker for colorectal cancer. Clin Chem. 55:1337–1346. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tänzer M, Balluff B, Distler J, Hale K,
Leodolter A, Röcken C, Molnar B, Schmid R, Lofton-Day C, Schuster T
and Ebert MP: Performance of epigenetic markers SEPT9 and ALX4 in
plasma for detection of colorectal precancerous lesions. PLoS One.
5:e90612010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ørntoft MB, Nielsen HJ, Ørntoft TF and
Andersen CL; and Danish Study Group on Early Detection of
Colorectal Cancer, . Performance of the colorectal cancer screening
marker Sept9 is influenced by age, diabetes and arthritis: A nested
case-control study. BMC Cancer. 15:8192015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Powrózek T, Krawczyk P, Kucharczyk T and
Milanowski J: Septin 9 promoter region methylation in free
circulating DNA-potential role in noninvasive diagnosis of lung
cancer: Preliminary report. Med Oncol. 31:9172014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lyu N, Yao H, Xiao T, Gao Y and Wu L:
[Protein levels and its clinical significance of septin-9 and
clusterin in peripheral blood of epithelial ovarian cancer
patients). Zhonghua Fu Chan Ke Za Zhi. 50:679–684. 2015.(In
Chinese). PubMed/NCBI
|
|
20
|
Kreuziger LM, Porcher JC, Ketterling RP
and Steensma DP: An MLL-SEPT9 fusion and t(11;17) (q23;q25)
associated with de novo myelodysplastic syndrome. Leuk Res.
31:1145–1148. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bennett KL, Karpenko M, Lin MT, Claus R,
Arab K, Dyckhoff G, Plinkert P, Herpel E, Smiraglia D and Plass C:
Frequently methylated tumor suppressor genes in head and neck
squamous cell carcinoma. Cancer Res. 68:4494–4499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Molnár B, Tóth K, Barták BK and Tulassay
Z: Plasma methylated septin 9: A colorectal cancer screening
marker. Expert Rev Mol Diagn. 15:171–184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Whiting PF, Rutjes AW, Westwood ME,
Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA and Bossuyt
PM: QUADAS-2 Group: QUADAS-2: A revised tool for the quality
assessment of diagnostic accuracy studies. Ann Intern Med.
155:529–536. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Pei F, Wang X, Sun Z, Hu C and Dou
H: Diagnostic accuracy of fecal lactoferrin for inflammatory bowel
disease: A meta-analysis. Int J Clin Exp Pathol. 8:12319–12332.
2015.PubMed/NCBI
|
|
25
|
Cao FF, Yu S, Jiang ZY and Bao YX:
Diagnostic accuracy of Golgi protein 73 in primary hepatic
carcinoma using ELISA: A systematic review and meta-analysis. Clin
Lab. 60:587–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tóth K, Galamb O, Spisák S, Wichmann B,
Sipos F, Valcz G, Leiszter K, Molnár B and Tulassay Z: The
influence of methylated septin 9 gene on RNA and protein level in
colorectal cancer. Pathol Oncol Res. 17:503–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang C, Zhao K and Rong Q: Diagnostic
value of fecal MicroRNAs for colorectal cancer: A meta-analysis.
Clin Lab. 61:1845–1853. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui Z, Chen Y, Xiao Z, Hu M, Lin Y, Chen Y
and Zheng Y: Long noncoding RNAs as auxiliary biomarkers for
gastric cancer screening: A pooled analysis of individual studies.
Oncotarget. 7:25791–25800. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu H, Bhagatwala J, Huang Y, Pollock NK,
Parikh S, Raed A, Gutin B, Harshfield GA and Dong Y: Correction:
Race/ethnicity-specific association of vitamin D and global DNA
methylation: Cross-sectional and interventional findings. PLoS One.
11:e01625822016. View Article : Google Scholar : PubMed/NCBI
|
